Review



type i mglur agonist dhpg  (Tocris)


Bioz Verified Symbol Tocris is a verified supplier
Bioz Manufacturer Symbol Tocris manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Tocris type i mglur agonist dhpg
    (A–D). QMI maps showing network biosignatures for A. 100 μM glutamate, B. 1μM glutamate, C. <t>100μM</t> NMDA+10μm Glycine, D. 100μm <t>DHPG</t> for N=4–8 biological replicates. (E) Principal component analysis showing separation of NMDA <t>and</t> <t>mGluR</t> treatment along opposing axes, with glutamate intermediate. (F) Topological overlap matrix with significant modules boxed as in Figure 4. (G) Module-trait matrix showing Turquoise module correlated with NMDA stimulation, and the Brown module correlated with DHPG.
    Type I Mglur Agonist Dhpg, supplied by Tocris, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/type i mglur agonist dhpg/product/Tocris
    Average 90 stars, based on 1 article reviews
    type i mglur agonist dhpg - by Bioz Stars, 2026-02
    90/100 stars

    Images

    1) Product Images from "Synaptic activity induces input-specific rearrangements in a targeted synaptic protein interaction network"

    Article Title: Synaptic activity induces input-specific rearrangements in a targeted synaptic protein interaction network

    Journal: Journal of neurochemistry

    doi: 10.1111/jnc.14466

    (A–D). QMI maps showing network biosignatures for A. 100 μM glutamate, B. 1μM glutamate, C. 100μM NMDA+10μm Glycine, D. 100μm DHPG for N=4–8 biological replicates. (E) Principal component analysis showing separation of NMDA and mGluR treatment along opposing axes, with glutamate intermediate. (F) Topological overlap matrix with significant modules boxed as in Figure 4. (G) Module-trait matrix showing Turquoise module correlated with NMDA stimulation, and the Brown module correlated with DHPG.
    Figure Legend Snippet: (A–D). QMI maps showing network biosignatures for A. 100 μM glutamate, B. 1μM glutamate, C. 100μM NMDA+10μm Glycine, D. 100μm DHPG for N=4–8 biological replicates. (E) Principal component analysis showing separation of NMDA and mGluR treatment along opposing axes, with glutamate intermediate. (F) Topological overlap matrix with significant modules boxed as in Figure 4. (G) Module-trait matrix showing Turquoise module correlated with NMDA stimulation, and the Brown module correlated with DHPG.

    Techniques Used:



    Similar Products

    type i mglur agonist dhpg  (Tocris)
    90
    Tocris type i mglur agonist dhpg
    (A–D). QMI maps showing network biosignatures for A. 100 μM glutamate, B. 1μM glutamate, C. <t>100μM</t> NMDA+10μm Glycine, D. 100μm <t>DHPG</t> for N=4–8 biological replicates. (E) Principal component analysis showing separation of NMDA <t>and</t> <t>mGluR</t> treatment along opposing axes, with glutamate intermediate. (F) Topological overlap matrix with significant modules boxed as in Figure 4. (G) Module-trait matrix showing Turquoise module correlated with NMDA stimulation, and the Brown module correlated with DHPG.
    Type I Mglur Agonist Dhpg, supplied by Tocris, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/type i mglur agonist dhpg/product/Tocris
    Average 90 stars, based on 1 article reviews
    type i mglur agonist dhpg - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    (A–D). QMI maps showing network biosignatures for A. 100 μM glutamate, B. 1μM glutamate, C. 100μM NMDA+10μm Glycine, D. 100μm DHPG for N=4–8 biological replicates. (E) Principal component analysis showing separation of NMDA and mGluR treatment along opposing axes, with glutamate intermediate. (F) Topological overlap matrix with significant modules boxed as in Figure 4. (G) Module-trait matrix showing Turquoise module correlated with NMDA stimulation, and the Brown module correlated with DHPG.

    Journal: Journal of neurochemistry

    Article Title: Synaptic activity induces input-specific rearrangements in a targeted synaptic protein interaction network

    doi: 10.1111/jnc.14466

    Figure Lengend Snippet: (A–D). QMI maps showing network biosignatures for A. 100 μM glutamate, B. 1μM glutamate, C. 100μM NMDA+10μm Glycine, D. 100μm DHPG for N=4–8 biological replicates. (E) Principal component analysis showing separation of NMDA and mGluR treatment along opposing axes, with glutamate intermediate. (F) Topological overlap matrix with significant modules boxed as in Figure 4. (G) Module-trait matrix showing Turquoise module correlated with NMDA stimulation, and the Brown module correlated with DHPG.

    Article Snippet: Type I mGluR agonist DHPG (Tocris, 0805; 100μM) was dissolved in HEPES-aCSF in the presence of non-mGluR glutamate receptor blockers (CNQX, Tocris, 0190, 40μM; Nimodipine, Tocris, 0600, 1μM; APV, Sigma, A5282, 50μM).

    Techniques: